Medicine price: quote on request. Every case gets a written custom quote before you commit. Your total cost is quoted per case.
Written estimate for your caseGet my quote

Is Tecelra available in Bahrain? How families get Tecelra (afamitresgene autoleucel)

Creator: Reserve Meds
Published: 2026-10-17

A plain answer for families in Bahrain, checked against FDA, manufacturer and regulator sources.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Is Tecelra available in Bahrain?

Tecelra (afamitresgene autoleucel) is an FDA-approved one-time engineered T-cell therapy made from the patient's own immune cells for advanced synovial sarcoma (MAGE-A4 positive, with specific HLA types). Tecelra is not on NHRA's Registered Medicine Price List (version dated 7 September 2026, 5,560 entries) or on its Temporary Importation Medicines List (dated 19 January 2025). We checked both on 17 October 2026. Tecelra is given only at specialized treatment centers, so for most families in Bahrain the realistic route is treatment at a qualified center abroad, after a referral from the treating specialist. If a hospital in Bahrain wants to give it locally, the manufacturer must agree to supply that hospital and the National Health Regulatory Authority (NHRA) must approve the import. Reserve Meds helps organize the referral and logistics. We do not prescribe.

Registration in Bahrain: not on NHRA's registered list (7 September 2026) or temporary importation list (19 January 2025), checked 17 October 2026.
Legal route: Treatment at a qualified center abroad, or a hospital import request if the manufacturer agrees.
Who applies: your treating specialist refers the patient to a qualified center; a hospital in Bahrain applies to NHRA only if the manufacturer agrees to supply it.
Timeline: We give you a written timeline estimate once we see the hospital file. The regulator and the manufacturer set their own timelines.
Medicine price: quote on request. Every case gets a written custom quote before you commit.

What Tecelra is

Tecelra (afamitresgene autoleucel) is made by USWM CT, LLC (the manufacturer named on the June 2026 US label; the FDA first approved it for Adaptimmune). The US FDA approved it on 1 August 2024 for adults and children 12 years and older with synovial sarcoma that cannot be removed by surgery or has spread, who have had chemotherapy before, who carry certain HLA-A*02 tissue types, and whose tumor expresses the MAGE-A4 protein on an FDA-approved or cleared test. It is given as a single intravenous (IV) infusion of the patient's own T cells, which are collected by leukapheresis, modified in a manufacturing facility, and given after lymphodepleting chemotherapy.

In the SPEARHEAD-1 trial described in the US label, the tumor shrank in 43.8% of the 137 treated patients. In June 2026 the FDA updated the label to include patients 12 and older and removed the accelerated approval statement. It has a boxed warning for cytokine release syndrome, which can be severe or life-threatening. The label also warns about nerve-related side effects (ICANS), long-lasting low blood counts and infections.

We did not find it in SFDA's public Drugs List or in Abu Dhabi's drug code list when we checked on 17 October 2026.

Registration status in Bahrain

NHRA updates its lists. Ask the hospital pharmacy to confirm the current status with NHRA's pharmaceutical products regulation section before anything is filed.

The legal route in Bahrain

Tecelra is made from each patient's own T cells. The cells are collected, sent for manufacture and given back as a single infusion after chemotherapy, by a team ready to treat cytokine release syndrome. The US label reports a 7% chance of manufacturing or shipping failure in the trial. At launch in 2024 the company planned to offer it through designated treatment centers in the United States.

For a family in Bahrain, that leaves two realistic routes. First, treatment at a qualified center abroad, after your specialist refers you and the center accepts the patient. Second, a hospital in Bahrain asks the manufacturer, USWM CT, LLC, whether it will supply that hospital. If the manufacturer agrees, the hospital still needs import approval from the National Health Regulatory Authority (NHRA). We cannot promise that a manufacturer will agree.

How a hospital import request works in Bahrain, if it is ever needed:

Under NHRA Circular No. (41) of 2020, government and private hospitals must get NHRA's permission before they issue a purchase order for a medicine that is not registered in Bahrain.

The circular asks that the medicine is important and has no registered alternative in Bahrain, is registered with the Gulf Health Council or in a GCC country, is registered with a reference authority such as the US FDA, and is marketed in its country of origin.

Some medicines for rare diseases, emergencies and tumors with no registered alternative can be excused from the registration and marketing conditions, through NHRA's list of emergency medicines or with Board approval.

The request goes to NHRA by email with the application form, a Certificate of Pharmaceutical Product (CPP) or registration certificate from a reference authority, and a Good Manufacturing Practice (GMP) certificate. NHRA's 2022 application form is signed by the importing hospital, the agent or the marketing authorization holder, who takes full responsibility for the product's quality and safety.

Who does what

Your treating specialist decides whether Tecelra is right for the patient and writes the letter.
The hospital refers the patient, or files a local import request if that becomes possible.
The National Health Regulatory Authority (NHRA) decides whether to approve an import of a medicine that is not registered.
USWM CT, LLC makes Tecelra and decides where it can be supplied.
Reserve Meds can help organize records and logistics, and keeps your family updated. We do not give medical advice.

Documents you will usually need

A referral letter from the treating specialist: diagnosis, test results and why this treatment is being considered
Genetic or laboratory reports that confirm the diagnosis, translated into English where needed
Recent clinic notes, imaging and a list of past treatments
Passport and travel documents, if treatment happens abroad
A funding plan: personal funds, insurer approval, or a government treatment-abroad decision

Timeline, step by step

Referral. Your specialist prepares a referral letter and the medical records.
Center review. A qualified treatment center reviews the records and decides whether the patient is eligible.
Funding and travel. The family confirms funding and plans travel and accommodation.
Preparation. The center runs tests and, for some products, collects cells or tissue to make the treatment.
Treatment and follow-up. The patient is treated and then followed up by the center and the home specialist.

We give you a written timeline estimate once we see the hospital file. The regulator and the manufacturer set their own timelines.

What Tecelra costs

Medicine price: quote on request. Your total cost depends on the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. We do not prescribe, and we do not decide what the regulator approves.

Ask us about Tecelra in Bahrain

Tell us the medicine, the country, and how to reach you. We reply within one business day. On WhatsApp we usually reply the same day.

Message us on WhatsApp Already have a case? Sign in

Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Frequently asked questions

Is Tecelra approved in Bahrain?

Tecelra is not on NHRA's Registered Medicine Price List (version dated 7 September 2026, 5,560 entries) or on its Temporary Importation Medicines List (dated 19 January 2025). We checked both on 17 October 2026. The same registered list does include other specialty therapies, such as Zolgensma, Casgevy and Elevidys, so it does cover this kind of medicine. NHRA updates its lists. Ask the hospital pharmacy to confirm the current status with NHRA's pharmaceutical products regulation section before anything is filed.

Who applies for permission to use Tecelra in Bahrain?

For treatment abroad, your specialist refers the patient to a qualified center. For a local hospital import, the hospital applies to the National Health Regulatory Authority (NHRA), and the manufacturer must agree to supply.

How long does it take to get Tecelra in Bahrain?

It depends on the center's review, the patient's eligibility and how long the treatment takes to prepare. We give you a written timeline estimate once we see the hospital file. The regulator and the manufacturer set their own timelines.

How much does Tecelra cost?

Medicine price: quote on request. Your total cost, including shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Can Tecelra be given in Bahrain instead of abroad?

Only if the manufacturer agrees to supply a hospital in Bahrain and NHRA approves the import. We will tell you honestly if that is not possible today.

Sources

Checked on 17 October 2026. Regulator rules and lists change. Your hospital pharmacy confirms the current procedure before filing.